Can-Fite BioPharma Ltd. (CANF) Capital expenditures 2017–2025
Can-Fite BioPharma Ltd. (CANF) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$2,000FY2025 · since FY2017: $7,000 → $2,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $2,000 | -60.0% |
| FY2024 | $5,000 | +150.0% |
| FY2023 | $2,000 | -77.8% |
| FY2022 | $9,000 | -18.2% |
| FY2021 | $11,000 | -57.7% |
| FY2020 | $26,000 | +766.7% |
| FY2019 | $3,000 | -90.9% |
| FY2018 | $33,000 | +371.4% |
| FY2017 | $7,000 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice